Edoceo Devices is an emerging med-tech & biotech American company with Exclusive & Groundbreaking Biosensor Technology that could Help in the fight against COVID-19 – as well as Future Viral & Bacterial Threats to our families and our normal way of life.
Being able to detect viral infections & harmful bacteria within minutes, can be described as a game-changer in the fight against superbugs, starting with the Edoceo CE Certified A-Detect™ for simple COVID-19 testing of saliva samples at point-of-need.
The Edoceo sensors’ ability to give almost instantaneous warnings of infectious outbreaks will enable early treatments & solutions, saving production facilities & the health care system potentially billions of dollars &, we believe, many lives.
respond to an immediate market need, and to leverage a potential additional
revenue source that can also help speed development of the ground-breaking
V-Detect and B-Detect devices, the Team at Edoceo has recently secured a
worldwide strategic and preferred distribution agreement for a simple, rapid,
and affordable COVID-19 antigen test that provides results in 17 minutes or
less by testing saliva for Coronavirus antigens.
Already approved for the European market, where over 213 million tests have been carried out so far in 2020, we will shortly begin sales through multiple agents located in the 33 countries that require CE marking. We are also planning a US FDA approval for distribution and sales in the United States. Our current supply capacity is up to 200,000 units per day, 73 million per year – with the advantage of commercially positioning Edoceo Devices in the rapid-testing pathogen marketplace – ideal for when the superior V-Detect and B-Detect devices are ready for their commercialization.learn more
If looking for more information about possible investment opportunities in Edoceo Devices, please see here...Investment Info